GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Enterprise Value

Getinge AB (OSTO:GETI B) Enterprise Value : kr59,892 Mil (As of May. 16, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Getinge AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Getinge AB's Enterprise Value is kr59,892 Mil. Getinge AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was kr3,862 Mil. Therefore, Getinge AB's EV-to-EBIT ratio for today is 15.51.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Getinge AB's Enterprise Value is kr59,892 Mil. Getinge AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was kr6,378 Mil. Therefore, Getinge AB's EV-to-EBITDA ratio for today is 9.39.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Getinge AB's Enterprise Value is kr59,892 Mil. Getinge AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was kr35,566 Mil. Therefore, Getinge AB's EV-to-Revenue ratio for today is 1.68.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Getinge AB's Enterprise Value is kr59,892 Mil. Getinge AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was kr2,484 Mil. Therefore, Getinge AB's EV-to-FCF ratio for today is 24.11.


Getinge AB Enterprise Value Historical Data

The historical data trend for Getinge AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Enterprise Value Chart

Getinge AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56,934.28 108,270.39 59,476.63 66,677.59 57,419.77

Getinge AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63,887.50 55,591.22 68,221.56 57,419.77 66,251.45

Competitive Comparison of Getinge AB's Enterprise Value

For the Medical Devices subindustry, Getinge AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Getinge AB's Enterprise Value falls into.


;
;

Getinge AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Getinge AB's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Getinge AB's Enterprise Value for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Getinge AB  (OSTO:GETI B) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Getinge AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=59891.524/3862
=15.51

Getinge AB's current Enterprise Value is kr59,892 Mil.
Getinge AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,862 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Getinge AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=59891.524/6378
=9.39

Getinge AB's current Enterprise Value is kr59,892 Mil.
Getinge AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6,378 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Getinge AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=59891.524/35566
=1.68

Getinge AB's current Enterprise Value is kr59,892 Mil.
Getinge AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr35,566 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Getinge AB's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=59891.524/2484
=24.11

Getinge AB's current Enterprise Value is kr59,892 Mil.
Getinge AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2,484 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Getinge AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of Getinge AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB Business Description

Traded in Other Exchanges
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB Headlines

No Headlines